NORCEMIC Trademark

Trademark Overview


On Saturday, July 13, 2024, a trademark application was filed for NORCEMIC with the United States Patent and Trademark Office. The USPTO has given the NORCEMIC trademark a serial number of 98647239. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, February 10, 2025. The NORCEMIC trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus for monitoring blood glucose levels
norcemic

General Information


Serial Number98647239
Word MarkNORCEMIC
Filing DateSaturday, July 13, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, February 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Goods and ServicesMedical apparatus for monitoring blood glucose levels

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, July 13, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMaricopa, AZ 85139

Trademark Events


Event DateEvent Description
Saturday, July 13, 2024NEW APPLICATION ENTERED
Saturday, July 13, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, February 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 5, 2025ASSIGNED TO EXAMINER
Thursday, February 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 6, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, February 6, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 6, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, February 6, 2025EXAMINER'S AMENDMENT ENTERED